World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
56
Citations
11302
World Ranking
4523
National Ranking
261

José N. Nobrega publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where José N. Nobrega sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 246 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

José N. Nobrega D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where José N. Nobrega sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 56 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

José N. Nobrega is affiliated with the Centre for Addiction and Mental Health in Canada. Their research spectrum primarily covers Medicine, Neuroscience, and Biochemistry, Genetics and Molecular Biology, with a significant focus on Molecular Biology and Cellular and Molecular Neuroscience.

Their work addresses topics such as Intensive Care Unit Cognitive Disorders, Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research, Blood Pressure and Hypertension Studies, Epigenetics and DNA Methylation, and Regulation of Appetite and Obesity.

Recent publications include:

  • Effects of exposure to chronic uncertainty and a sensitizing regimen of amphetamine injections on locomotion, decision-making, and dopamine receptors in rats, 2020, Neuropsychopharmacology
  • Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder, 2020, Neuropharmacology
  • Antidepressant activity of pharmacological and genetic deactivation of the small-conductance calcium-activated potassium channel subtype-3, 2022, Psychopharmacology
  • Relationships Between a New Cultured Cell-Based Serum Anticholinergic Activity Assay and Anticholinergic Burden Scales or Cognitive Performance in Older Adults, 2021, American Journal of Geriatric Psychiatry
  • Antidepressant action of transcranial direct current stimulation in olfactory bulbectomised adolescent rats, 2021, Journal of Psychopharmacology

José N. Nobrega frequently publishes in several journals, including:

  • American Journal of Geriatric Psychiatry
  • Journal of Psychopharmacology
  • Biological Psychiatry
  • Neuropsychopharmacology
  • Psychopharmacology

Their frequent co-authors include Roger Raymond, Bruce G. Pollock, Tarek K. Rajji, Susmita Chandramouleeshwaran, and Corinne E. Fischer.

Best Publications

  • Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects

    Ian Mahar;Ian Mahar;Francis Rodriguez Bambico;Naguib Mechawar;José N. Nobrega

  • Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy

    Shitij Kapur;Susan C. VanderSpek;Barbara A. Brownlee;José N. Nobrega

  • Brain cytochrome oxidase in Alzheimer's disease.

    Stephen J. Kish;Catherine Bergeron;Ali Rajput;Slobodan Dozic

  • Antidepressant-Like Effects of Medial Prefrontal Cortex Deep Brain Stimulation in Rats

    Clement Hamani;Clement Hamani;Mustansir Diwan;Carlos E. Macedo;Marcus L. Brandão

  • 11C-labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer’s disease

    Masahiro Ono;Alan Wilson;Jose Nobrega;David Westaway

  • Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models

    Sridhar Natesan;Greg E Reckless;José N Nobrega;José N Nobrega;Paul J Fletcher;Paul J Fletcher

  • HETEROGENEOUS SUBREGIONAL BINDING PATTERNS OF 3H-WIN 35,428 AND 3H-GBR 12,935 ARE DIFFERENTIALLY REGULATED BY CHRONIC COCAINE SELF-ADMINISTRATION

    Julie M. Wilson;Jose N. Nobrega;Marilyn E. Carroll;Hyman B. Niznik

  • Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects

    Lin Pei;Shupeng Li;Min Wang;Mustansir Diwan

  • Sleep deprivation induces brain region-specific decreases in glutathione levels

    V D'Almeida;L L Lobo;D C Hipólide;A C de Oliveira

  • Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: role of serotonin and brain derived neurotrophic factor.

    Clement Hamani;Clement Hamani;Clement Hamani;Danilo C. Machado;Débora C. Hipólide;Francisco P. Dubiela

  • Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats.

    Clement Hamani;Clement Hamani;Mustansir Diwan;Silvia Isabella;Andres M. Lozano

  • In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.

    Eugenii A. Rabiner;Eugenii A. Rabiner;Mark Slifstein;Jose Nobrega;Christophe Plisson

  • Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model.

    Araba F. Chintoh;Araba F. Chintoh;Steve W. Mann;Steve W. Mann;Loretta Lam;Adria Giacca

  • Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter

    Alan A Wilson;David Patrick Johnson;David Mozley;Doug Hussey

  • Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine.

    Julie M. Wilson;JoséN. Nobrega;William A. Corrigall;Kathy M. Coen

  • Autoradiographic analysis of D1 and D2 dopaminergic receptors in rat brain after paradoxical sleep deprivation

    Unknown

  • Less Is More : Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery

    Anne-Noël Samaha;Greg E. Reckless;Philip Seeman;Mustansir Diwan

  • Gestational Methylazoxymethanol Acetate Treatment Impairs Select Cognitive Functions: Parallels to Schizophrenia

    Robert E Featherstone;Zoe Rizos;José N Nobrega;José N Nobrega;Shitij Kapur;Shitij Kapur

  • Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration.

    Araba F. Chintoh;Steve W. Mann;Loretta Lam;Carol Lam

  • The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D2 receptor occupancy?

    Peter Turrone;Gary Remington;Gary Remington;José N. Nobrega;José N. Nobrega

  • The Dopamine Stabilizers (S)-(-)-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-Methanesulfonylphenyl)-1-propyl-piperidine (ACR16) Show High in Vivo D2 Receptor Occupancy, Antipsychotic-Like Efficacy, and Low Potential for Motor Side Effects in the Rat

    Sridhar Natesan;Kjell A. Svensson;Greg E. Reckless;José N. Nobrega

  • Pain hypersensitivity induced by paradoxical sleep deprivation is not due to altered binding to brain μ-opioid receptors

    Danielle C Nascimento;Monica L Andersen;Débora Cristina Hipólide;José N Nobrega

Frequent Co-Authors

Clement Hamani
Clement Hamani University of Toronto
Shitij Kapur
Shitij Kapur King's College London
Paul J. Fletcher
Paul J. Fletcher Centre for Addiction and Mental Health
Gary Remington
Gary Remington Centre for Addiction and Mental Health
Alan A. Wilson
Alan A. Wilson Centre for Addiction and Mental Health
Sergio Tufik
Sergio Tufik Federal University of Sao Paulo
Sylvain Houle
Sylvain Houle University of Toronto
Stephen J. Kish
Stephen J. Kish Centre for Addiction and Mental Health
Philip Seeman
Philip Seeman University of Toronto
Tarek K. Rajji
Tarek K. Rajji Centre for Addiction and Mental Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing José N. Nobrega

Trending Scientists